Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
AstraZeneca Pharma India Limited (NSE: ASTRAZEN), ISIN INE203A01020 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ASTRAZEN last traded at ₹6709.20 (-0.04%), with a 52-week range of ₹6606.30 to ₹9850.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 75.00%, FIIs 2.68%, DIIs 6.08%, mutual funds 6.01%.
EquiSense Score (ECS): 56/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.